Eric Dobmeier
Officer, Director at Chinook Therapeutics, Inc. (KDNY)
Eric Dobmeier has filed 31 insider reports with the SEC since February 2021, as director at Structure Therapeutics Inc. (GPCR), director at Janux Therapeutics, Inc. (JANX) and director at Jade Biosciences, Inc. (JBIO) and at 3 more companies. Eric Dobmeier made no open-market purchases or sales in the last 12 months. The latest filing, on June 18, 2026, reports grant or award at Structure Therapeutics Inc. (GPCR).
- Filings
- 31
- Companies
- 6
- Bought on market
- $323K
- Sold on market
- $2.18M
Companies where Eric Dobmeier is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | $17.12 | Jun 18, 2026 | |||||
| Directorsince July 2024 | 15,481 | $10.29 | Jun 13, 2026 | ||||
| Directorsince April 2025 | $15.06 | May 1, 2025 | |||||
| Director | 563,325 | $101K | $0.23 | $6.34+2657% | Nov 14, 2023 | ||
| Officer, Director | 0 | $222K | $2.18M | $12.32 | Aug 11, 2023 | ||
| Director | 1,504 | $28.05 | Feb 18, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jun 17, 2026GPCRSEC Form 4 filed by Director Dobmeier EricForm 4Grant or award
- Jun 11, 2026JANXDirector Dobmeier Eric was granted 5,500 shares, increasing direct ownership by 55% to 15,481 unitsForm 4Grant or award
- Jun 23, 2025GPCRSEC Form 4 filed by Director Dobmeier EricForm 4Grant or award
- Jun 11, 2025JANXDirector Dobmeier Eric was granted 3,750 shares, increasing direct ownership by 60% to 9,981 unitsForm 4Grant or award
- Apr 29, 2025JBIOSEC Form 4 filed by Director Dobmeier EricForm 4Grant or award
- Apr 28, 2025JBIOEric Dobmeier became an insiderForm 3New insider
- Jul 19, 2024JANXAmendment: Director Dobmeier Eric was granted 1,231 shares, increasing direct ownership by 25% to 6,231 unitsForm 4Grant or award
- Jul 19, 2024JANXDirector Dobmeier Eric was granted 7,500 sharesForm 4Grant or award
- Jul 19, 2024JANXEric Dobmeier became an insiderForm 3New insider
- Jun 25, 2024GPCRSEC Form 4 filed by Director Dobmeier EricForm 4Grant or award
- Nov 10, 2023+$101KATRADobmeier Eric bought $101,340 worth of shares (446,825 units at $0.23), increasing direct ownership by 384% to 563,325 unitsForm 4Open-market purchase
- Aug 11, 2023KDNYSEC Form 4: Dobmeier Eric returned 301,138 shares to the company, closing all direct ownership in the companyForm 4Sale back to the company
- May 31, 2023ATRASEC Form 4 filed by Dobmeier EricForm 4Grant or award
- Apr 24, 2023-$514KKDNYSEC Form 4 filed by Dobmeier EricForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 10, 2023-$192KKDNYSEC Form 4: Dobmeier Eric converted options into 20,248 shares and sold $192,292 worth of shares (8,097 units at $23.75), increasing direct ownership by 4% to 301,138 units (withholding tax)Form 4Exercise or conversion of a derivativeOpen-market sale
- Jan 31, 2023-$803KKDNYSEC Form 4: Dobmeier Eric exercised 49,999 shares at a strike of $0.21 and sold $803,369 worth of shares (32,688 units at $24.58) as part of a pre-agreed trading plan, increasing direct ownership by 6% to 288,987 units (tax withholding)Form 4Grant or awardExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 14, 2022KDNYSEC Form 4: Dobmeier Eric exercised 30,000 shares at a strike of $0.35, increasing direct ownership by 12% to 271,676 unitsForm 4Exercise or conversion of a derivative
- Dec 1, 2022-$669KKDNYSEC Form 4: Dobmeier Eric exercised 60,000 shares at a strike of $0.42, sold $669,351 worth of shares (30,000 units at $22.31) as part of a pre-agreed trading plan and gifted 25,000 shares, increasing direct ownership by 2% to 241,676 unitsForm 4GiftExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Oct 6, 2022KDNYSEC Form 4: Dobmeier Eric converted options into 30,796 shares, increasing direct ownership by 15% to 236,676 unitsForm 4Exercise or conversion of a derivative
- Jun 23, 2022ATRASEC Form 4: Dobmeier Eric was granted 20,500 shares, increasing direct ownership by 53% to 59,500 unitsForm 4Grant or award
- May 25, 2022+$65.1KKDNYSEC Form 4: Dobmeier Eric bought $65,148 worth of shares (5,000 units at $13.03), increasing direct ownership by 2% to 205,880 unitsForm 4Open-market purchase
- Feb 10, 2022KDNYSEC Form 4: Dobmeier Eric converted options into 20,247 shares, increasing direct ownership by 11% to 200,880 unitsForm 4Exercise or conversion of a derivative
- Jan 31, 2022KDNYSEC Form 4 filed by Dobmeier EricForm 4Grant or award
- Dec 23, 2021KDNYSEC Form 4: Dobmeier Eric exercised 40,000 shares at a strike of $0.35, increasing direct ownership by 28% to 180,633 unitsForm 4Exercise or conversion of a derivative
- Oct 6, 2021KDNYSEC Form 4: Dobmeier Eric converted options into 30,796 shares, increasing direct ownership by 28% to 140,633 unitsForm 4Exercise or conversion of a derivative
- Sep 20, 2021+$24KKDNYSEC Form 4: Dobmeier Eric bought $24,000 worth of Common Stock (2,000 units at $12.00), increasing direct ownership by 2% to 109,837 unitsForm 4Open-market purchase
- Aug 19, 2021+$118KKDNYSEC Form 4: DOBMEIER ERIC bought $118,163 worth of Common Stock (10,000 units at $11.82), increasing direct ownership by 10% to 107,837 unitsForm 4Open-market purchase
- Jun 14, 2021KDNYSEC Form 4: DOBMEIER ERIC exercised 20,000 units of Common Stock at a strike of $0.35, increasing direct ownership by 26% to 97,837 unitsForm 4Exercise or conversion of a derivative
- May 14, 2021+$14.4KKDNYSEC Form 4: DOBMEIER ERIC bought $14,440 worth of Common Stock (1,000 units at $14.44), increasing direct ownership by 1% to 77,837 unitsForm 4Open-market purchase
- Feb 14, 2021ADPTSEC Form 4: Eric Dobmeier was granted 1,504 units of Common StockForm 4Grant or award
- Feb 10, 2021KDNYSEC Form 4 filed by Eric DobmeierForm 4Grant or award
Also sits on boards with
Officers and directors who share two or more companies with Eric Dobmeier.
- Michelle Renee Griffin2 shared: ADPT, KDNY
- Tom Frohlich2 shared: JBIO, KDNY
- Andrew James King2 shared: JBIO, KDNY
Compare Eric Dobmeier with
- Eric Dobmeier vs Michelle Renee Griffin2 shared
- Eric Dobmeier vs Tom Frohlich2 shared
- Eric Dobmeier vs Andrew James King2 shared
- Eric Dobmeier vs AnhCo Nguyen1 shared
- Eric Dobmeier vs Julie Rubinstein1 shared
- Eric Dobmeier vs Susan Bobulsky1 shared
Other insiders at the same companies
- AnhCo NguyenATRA
- Julie RubinsteinADPT
- Susan BobulskyADPT
- Chad M RobinsADPT
- Crespo Blas CollGPCR
- Francis LoADPT
- Brian N CherryATRA
- Xichen LinGPCR
- Katey Einterz OwenADPT
- Robert HershbergADPT
- Peter M NeupertADPT
- John Joseph BerriosGPCR
- David Alan CampbellJANX
- Redmile Group, LLCATRA
- Fmr LLCGPCR
- Harlan S RobinsADPT
Questions about Eric Dobmeier
- What is Eric Dobmeier's role at Chinook Therapeutics, Inc.?
- Eric Dobmeier reports to the SEC as officer and director at Chinook Therapeutics, Inc. (KDNY), according to the latest filing on August 11, 2023. Eric Dobmeier has also filed as director at Structure Therapeutics Inc. (GPCR), director at Janux Therapeutics, Inc. (JANX), director at Jade Biosciences, Inc. (JBIO) and director at Atara Biotherapeutics, Inc. (ATRA).
- How many shares does Eric Dobmeier own?
- After the latest filing that states it, Eric Dobmeier directly owned 15,481 shares of Janux Therapeutics, Inc. (JANX), 563,325 shares of Atara Biotherapeutics, Inc. (ATRA) and 1,504 shares of Adaptive Biotechnologies Corp (ADPT). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Eric Dobmeier bought or sold stock recently?
- The most recent open-market purchase was on November 10, 2023: bought 446,825 shares of Atara Biotherapeutics, Inc. (ATRA) for $101K at an average of $0.23. The most recent open-market sale was on April 24, 2023: sold 23,800 shares of Chinook Therapeutics, Inc. (KDNY) for $514K at an average of $21.58.
- How do I get alerts when Eric Dobmeier files?
- Follow Eric Dobmeier on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Eric Dobmeier (SEC CIK 0001202785). Totals count each trade once, skipping amendments whose original is on file, from Feb 12, 2021 on. View on SEC EDGAR · Get this as JSON